This patent is about the technology for manufacturing artificial blood vessels that can be implanted in the body using a 3D bioprinting method. It is a new concept of 3D bioprinting technology differentiated from the existing method through the fusion of polymer printing technology for external shape fixation and cell printing technology of microvascular tissue.
In particular, the technology prints the company's bio-inks and living cells together to produce artificial tubular tissues that are similar to the actual biological tissues. It can precisely implement not only structural shapes but also biological functions. Moreover, since it can also be applied to the production of artificial airways or artificial esophagus, as well as artificial blood vessels, it is expected to be further utilized in the future.
T&R Biofab said that if the technology is commercialized, it will be able to receive great response not only in domestic but also in overseas markets, and will offer innovative alternatives for the treatment of vascular diseases such as myocardial infarction and stroke. Besides, the company emphasized that it would focus on R&D to advance technology further and speed up the commercialization and industrialization.
Copyright © acrofan All Right Reserved
[CES 2021] LG Emphasized "Needs to Innovate Beyond..
[CES 2021] Sony Unveiled Its Latest Initiatives Sur..
Macan sets new standards: the first all-electric S..
Putting the new Macan through its paces in the nam..
G-Star 2019 : Global Game Exhibition for the Whole..
2019 LoL Champions Korea Spring Media Day
DISNEY+ Showcases Ambitious New Content Slate from..
eCommerce leader Coupang Dives into Video Streamin..